Figure 3From: A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI Forest plot of overall survival for the better and poorer efficacy subgroups. CI, confidence interval. Adjusted HR: Hazard ratio adjusted on baseline value of performance status, prior bevacizumab, age, hypertension and number of metastatic organs.Back to article page